Evidence mapPaperPMID 36176449Full record

ArticleFrontiers in pharmacology2022

Evaluation of two different

Guillermo Cásedas, Cristina Moliner, Filippo Maggi, Eugenia Mazzara, Víctor López

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Review
  3. Selected Cannabinoids, Cannabimimetic Agents andPharmaceuticals (Basel, Switzerland) · 2026
    Review
  4. Article
  5. Article
  6. Spectroscopy-Based Evaluation of the Antioxidant Capacity of Hemp (International journal of molecular sciences · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Evaluation of Commercially Available Products ofFoods (Basel, Switzerland) · 2025
    Article
  12. Review
  13. Review
  14. Current and Potential Use of Biologically Active Compounds Derived fromInternational journal of molecular sciences · 2024
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Charting the Cannabis plant chemical space with computational metabolomics.Metabolomics : Official journal of the Metabolomic Society · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Guillermo CásedasDepartment of Pharmacy, Faculty of Health Sciences, Universidad San Jorge, Zaragoza, Spain.
Cristina MolinerDepartment of Pharmacy, Faculty of Health Sciences, Universidad San Jorge, Zaragoza, Spain.
Filippo MaggiSchool of Pharmacy, University of Camerino, Camerino, Italy.
Eugenia MazzaraSchool of Pharmacy, University of Camerino, Camerino, Italy.
Víctor LópezDepartment of Pharmacy, Faculty of Health Sciences, Universidad San Jorge, Zaragoza, Spain.
Universidad San Jorge · ESUniversità di Camerino · ITCentro de Investigación y Tecnología Agroalimentaria de Aragón · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antioxidantcannabidiol (CBD)cannabinoidcentral nervous system (CNS)enzymatic inhibitionoxidative stresspolyphenoltrans-Δ-9-tetrahydrocannabinol (Δ9-THC)

Identifiers

PMID36176449
PMCPMC9513154
OpenAlexW4295538085

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.